FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1231572004: Prolonged-release transdermal delivery system (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5073465018 Prolonged-release transdermal delivery system (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5073466017 Prolonged-release transdermal delivery system en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal delivery system (dose form) Is a Transdermal dose form (dose form) true Inferred relationship Some
Prolonged-release transdermal delivery system (dose form) Has basic dose form (attribute) A solid dose form consisting of one or more components which together are used to deliver active substance(s) with a prolonged-release mechanism. true Inferred relationship Some
Prolonged-release transdermal delivery system (dose form) Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration to the skin in order to obtain an effect after absorption through the skin barrier. true Inferred relationship Some
Prolonged-release transdermal delivery system (dose form) Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release transdermal delivery system (dose form) Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release transdermal delivery system (dose form) Has dose form administration method (attribute) A method of administration of a dose form by placing or spreading on a body surface. true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start